News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Siffert Joao MD
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/21/2022 |
4
| Siffert Joao MD (President and CEO) has filed a Form 4 on Design Therapeutics, Inc.
Txns:
| Bought 1,150 shares
@ $8.47, valued at
$9.7k
Bought 6,300 shares
@ $8.375, valued at
$52.8k
|
|
02/02/2022 |
4
| Siffert Joao MD (President and CEO) has filed a Form 4 on Design Therapeutics, Inc.
Txns:
| Granted 475,000 options to buy
@ $12.77, valued at
$6.1M
|
|
03/25/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
05/22/2020 |
4
| Siffert Joao MD (CEO) has filed a Form 4 on ABEONA THERAPEUTICS INC.
Txns:
| Granted 100,000 shares
@ $0 Granted 72,296 options to buy
@ $3.2, valued at
$231.3k
|
|
03/18/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/18/2019 |
4
| Siffert Joao MD (CEO) has filed a Form 4 on ABEONA THERAPEUTICS INC.
Txns:
| Granted 60,000 options to buy
@ $6.59, valued at
$395.4k
Granted 110,000 options to buy
@ $6.7, valued at
$737k
|
|
04/11/2019 |
4
| Siffert Joao MD (CEO) has filed a Form 4 on ABEONA THERAPEUTICS INC.
Txns:
| Granted 100,000 options to buy
@ $7.24, valued at
$724k
|
|
04/11/2019 |
3
| Siffert Joao MD (Interim CEO) has filed a Form 3 on ABEONA THERAPEUTICS INC. |
05/15/2018 |
4
| Siffert Joao MD (Director) has filed a Form 4 on AveXis, Inc.
Txns:
| Disposed/sold 1,106 shares
@ $0 Disposed/sold 7,755 options to buy
@ $69.25, valued at
$537k
Disposed/sold 2,905 options to buy
@ $133.8, valued at
$388.7k
|
|
03/30/2018 |
4
| Siffert Joao MD (Director) has filed a Form 4 on AveXis, Inc.
Txns:
| Granted 1,106 shares
@ $0 Granted 2,905 options to buy
@ $133.8, valued at
$388.7k
|
|
06/01/2017 |
4
| Siffert Joao MD (Director) has filed a Form 4 on AveXis, Inc.
Txns:
| Granted 2,454 options to buy
@ $69.25, valued at
$169.9k
Granted 5,301 options to buy
@ $69.25, valued at
$367.1k
|
|
06/01/2017 |
3
| Siffert Joao MD (Director) has filed a Form 3 on AveXis, Inc. |
12/22/2014 |
4
| Siffert Joao MD (SVP, R&D) has filed a Form 4 on AVANIR PHARMACEUTICALS, INC.
Txns:
| Paid exercise price by delivering 19,204 shares
@ $16.99, valued at
$326.3k
Sold 15,505 shares
@ $16.93, valued at
$262.5k
Exercised 32,291 options to buy
@ $2.59, valued at
$83.6k
|
|
11/12/2014 |
4
| Siffert Joao MD (SVP, R&D) has filed a Form 4 on AVANIR PHARMACEUTICALS, INC.
Txns:
| Granted 59,231 shares
@ $0 Granted 34,825 shares
@ $0 |
|
10/24/2014 |
4
| Siffert Joao MD (SVP, R&D) has filed a Form 4 on AVANIR PHARMACEUTICALS, INC.
Txns:
| Sold 8,426 shares
@ $11.8, valued at
$99.4k
|
|
05/30/2014 |
4
| Siffert Joao MD (SVP, R&D) has filed a Form 4 on AVANIR PHARMACEUTICALS, INC.
Txns:
| Sold 13,547 shares
@ $5.18, valued at
$70.2k
Exercised 10,547 options to buy
@ $1.85, valued at
$19.5k
|
|
02/14/2014 |
4
| Siffert Joao MD (SVP, R&D) has filed a Form 4 on AVANIR PHARMACEUTICALS, INC.
Txns:
| Granted 80,750 shares
@ $0 Granted 43,000 shares
@ $0 |
|
12/20/2013 |
4
| Siffert Joao MD (SVP, R&D) has filed a Form 4 on AVANIR PHARMACEUTICALS, INC.
Txns:
| Sold 5,970 shares
@ $2.632, valued at
$15.7k
|
|
12/17/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
09/19/2013 |
4
| Siffert Joao MD (SVP, R&D) has filed a Form 4 on AVANIR PHARMACEUTICALS, INC.
Txns:
| Sold 21,094 shares
@ $4.2177, valued at
$89k
Exercised 21,094 options to buy
@ $1.85, valued at
$39k
|
|
12/19/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
05/14/2012 |
4
| Siffert Joao MD (SVP, R&D) has filed a Form 4 on AVANIR PHARMACEUTICALS, INC.
Txns:
| Bought 2,700 shares
@ $2.96, valued at
$8k
|
|
12/16/2011 |
4
| Siffert Joao MD (SVP, R&D) has filed a Form 4 on AVANIR PHARMACEUTICALS, INC.
Txns:
| Granted 8,125 shares
@ $0 Granted 21,375 shares
@ $0 Granted 56,250 options to buy
@ $1.85, valued at
$104.1k
|
|
11/18/2011 |
3
| Siffert Joao MD (SVP, R&D) has filed a Form 3 on AVANIR PHARMACEUTICALS, INC. |
|
|